Yasmine Van Caeneghem

The checkpoint for agonist selection precedes conventional selection in human thymus

Greet Verstichel, David Vermijlen, Liesbet Martens et al. · Science Immunology · 2017 · 57 citations · Full text

Life Sciences, Cell Biology, Immunology +11

In vitro human embryonic stem cell hematopoiesis mimics MYB-independent yolk sac hematopoiesis

Stijn Vanhee, Katrien De Mulder, Yasmine Van Caeneghem et al. · Haematologica · 2014 · 49 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +16

Gene Correction of iPSCs from a Wiskott-Aldrich Syndrome Patient Normalizes the Lymphoid Developmental and Functional Defects

Tamara Laskowski, Yasmine Van Caeneghem, Rasoul Pourebrahim et al. · Stem Cell Reports · 2016 · 46 citations · Full text

Life Sciences, Genetics, Molecular Genetics +12

RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia

Sylvia Snauwaert, Stijn Vanhee, Glenn Goetgeluk et al. · Haematologica · 2012 · 34 citations · Full text

Medicine, Immunology, Oncology +15

Antigen receptor-redirected T cells derived from hematopoietic precursor cells lack expression of the endogenous TCR/CD3 receptor and exhibit specific antitumor capacities

Yasmine Van Caeneghem, Stijn De Munter, Paola Tieppo et al. · OncoImmunology · 2017 · 30 citations · Full text

Life Sciences, Hematology, Immunology +17